Israel - English - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 200 mg / 5 ml - valproic acid - valproic acid - sole or adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. valporal may also be used adjunctively in patients with multiple seizure types which include absence seizures.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - solution (oral) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

United States - English - NLM (National Library of Medicine)

roerig - trovafloxacin mesylate (unii: 0p1lko80wn) (trovafloxacin - unii:9f388j00uk) - tablet, film coated - 100 mg - trovan is indicated for the treatment of patients initiating therapy in in-patient health care facilities (i.e., hospitals and long term nursing care facilities) with serious, life- or limb-threatening infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration .) nosocomial pneumonia caused by escherichia coli, pseudomonas aeruginosa, haemophilus influenzae , or staphylococcus aureus . as with other antimicrobials, where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with either an aminoglycoside or aztreonam may be clinically indicated. community acquired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, klebsiella pneumoniae, staphylococcus aureus, mycoplasma pneumoniae, moraxella catarrhalis, legionella pneumophila, or chlamydia pneumoniae . complicated intra-abdominal infections, including post-surgical infections caused by escherichia coli, bacteroides fragilis, vir

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for injection/infusion - aztreonam 2000 mg - antibacterials for systemic use

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for injection/infusion - aztreonam 2 g - antibacterials for systemic use

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for injection - aztreonam 1 g - antibacterials for systemic use

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for injection - aztreonam 1 g - antibacterials for systemic use

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - ceftaroline fosamil 600 mg eqv ceftaroline - injection, powder, for solution - 530 mg/vial - ceftaroline fosamil 600 mg eqv ceftaroline 530 mg/vial